138 related articles for article (PubMed ID: 4388267)
1. Antibiotic production by new form-genera of the Actinomycetales. I. Sporangiomycin, an antibacterial agent isolated from Planomonospora parontospora var. antibiotica var. nov.
Thiemann JE; Coronelli C; Pagani H; Beretta G; Tamoni G
J Antibiot (Tokyo); 1968 Sep; 21(9):525-31. PubMed ID: 4388267
[No Abstract] [Full Text] [Related]
2. [Antibacterial properties of lincomycin in vitro and its chemotherapeutic activity].
Shorin VA; Pevzner NS
Antibiotiki; 1968 Sep; 13(9):810-5. PubMed ID: 4387685
[No Abstract] [Full Text] [Related]
3. Clinical evaluation of laboratory guidance to antibiotic therapy.
Isenberg HD
Health Lab Sci; 1967 Jul; 4(3):166-80. PubMed ID: 4382258
[No Abstract] [Full Text] [Related]
4. Enduracidin, a new antibiotic. 3. In vitro and in vivo antimicrobial activity.
Tsuchiya K; Kondo M; Oishi T; Yamazaki I
J Antibiot (Tokyo); 1968 Feb; 21(2):147-53. PubMed ID: 4386300
[No Abstract] [Full Text] [Related]
5. [The antibacterial and chemotherapeutic activity of the Soviet produced antibiotic rifamitsina SV].
Shorin VA; Shapovalova SP
Antibiotiki; 1974 Jan; 19(1):3-6. PubMed ID: 4156904
[No Abstract] [Full Text] [Related]
6. Cyclacillin, a semisynthetic aminoalicyclic penicillin. I. Antibacterial activity in vitro and in vivo compared with ampicillin and cephalexin.
Yurchenco JA; Hopper MW; Vince TD; Warren GH
Chemotherapy; 1970; 15(4):209-21. PubMed ID: 4394267
[No Abstract] [Full Text] [Related]
7. [Antibacterial effect of rifampicin and its chemotherapeutic properties in experiments on animals].
Shorin VA; Shapovalova SP; Malkova IV
Antibiotiki; 1974 Dec; 19(12):1084-8. PubMed ID: 4155605
[No Abstract] [Full Text] [Related]
8. [Production of a new antibiotic, chalcidin, from Micromonospora chalcea culture].
Gauze GF; Brazhnikova MG; Shorin VA; Maksimova TS; Ol'khovatova OL; Kudinova MK; Vishniakova IA; Pevzner NS; Shapovalova SP
Antibiotiki; 1970 Jun; 15(6):483-6. PubMed ID: 4394064
[No Abstract] [Full Text] [Related]
9. [Value of quantitative bacteriological examination of sputum in the evaluation of the effectiveness of chemotherapy of bacterial respiratory tract infections. II. Clinical studies].
Nikodemowicz E; Owsiński J; Przybyłkiewicz Z; Kasprowicz A; Maternowska W; Kamińska M; Walaszek K; Prus F
Pneumonol Pol; 1980 Aug; 48(8):545-22. PubMed ID: 6968434
[No Abstract] [Full Text] [Related]
10. [Evaluation of antibiotic activity. Clinical evaluation of data obtained in vitro from antibiograms].
Giunchi G
Antibiotica; 1966 Sep; 4(3):149-68. PubMed ID: 5991414
[No Abstract] [Full Text] [Related]
11. Letter: New antibacterial agent via photofluorination of a bacterial cell wall constituent.
Kollonitsch J; Barash L; Kahan FM; Kropp H
Nature; 1973 Jun; 243(5406):346-7. PubMed ID: 4147634
[No Abstract] [Full Text] [Related]
12. [Use of the automated system for bacteriological diagnosis of suppurative complications].
Imshenetskaia VF
Antibiot Khimioter; 1990 Oct; 35(10):41-3. PubMed ID: 2278498
[TBL] [Abstract][Full Text] [Related]
13. Biological characterization of diumycin, a phosphorus-containing glycolipid antibiotic.
Meyers E; Slusarchyk DS; Pansy FE; Basch HI; Trejo WH
J Antibiot (Tokyo); 1972 Mar; 25(3):163-70. PubMed ID: 5034812
[No Abstract] [Full Text] [Related]
14. [Drug therapy using sulfonamides in dentistry, stomatology and gnathology. 4. Bacteriologic and morphologic-pathologic principles in the use of sulfonamides].
Bethmann W; Fassauer H; Schottke C; Langanke B
Dtsch Stomatol; 1973 Dec; 23(12):903-12. PubMed ID: 4149938
[No Abstract] [Full Text] [Related]
15. [Antibiotics for recurrent acute otitis media in infants under two (author's transl)].
Bláhová O; Drastík J
Z Laryngol Rhinol Otol; 1973 Nov; 52(11):802-7. PubMed ID: 4149361
[No Abstract] [Full Text] [Related]
16. Maridomycin, a new macrolide antibiotic. 3. In vitro and in vivo antibacterial activity.
Kondo M; Oishi T; Ishifuji K; Tsuchiya K
J Antibiot (Tokyo); 1973 Apr; 26(4):206-14. PubMed ID: 4782049
[No Abstract] [Full Text] [Related]
17. [Value of quantitative bacteriological examination of sputum in the evaluation of the effectiveness of chemotherapy of bacterial respiratory tract infections. I. Bacteriological studies].
Przybyłkiewicz Z; Nikodemowicz E; Kasprowicz A; Owsiński J
Pneumonol Pol; 1980 Aug; 48(8):535-43. PubMed ID: 6775309
[No Abstract] [Full Text] [Related]
18. Clinical outcome of pneumococcal bacteremia, in vitro resistance, and antibiotic therapy.
Torres-Tortosa M; Caballero-Granado J; Canueto J; Moreno-Maqueda I
Clin Infect Dis; 2004 Mar; 38(5):763-4; author reply 765-6. PubMed ID: 14986265
[No Abstract] [Full Text] [Related]
19. Purulent pericarditis in the antibiotic era.
Gould K; Barnett JA; Sanford JP
Arch Intern Med; 1974 Nov; 134(5):923-7. PubMed ID: 4155282
[No Abstract] [Full Text] [Related]
20. [Treatment of bacterial endocarditis].
Halawa B
Wiad Lek; 1982 Nov; 35(19-20):1257-64. PubMed ID: 6819721
[No Abstract] [Full Text] [Related]
[Next] [New Search]
